Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV
NCT05385510
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
122
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
BIOLOGICAL:
R21/Matrix-M™
Sponsor
University of Oxford
Collaborators
[object Object]